Is thyssenkrupp nucera KGaA (XTRA:NCH2) Undervalued On Its India Green Hydrogen Deal?
thyssenkrupp nucera KGaA (XTRA:NCH2) is back in focus after signing a collaboration agreement with Bharat Heavy Electricals Limited to localize alkaline water electrolyzer manufacturing for green hydrogen projects in India.
See our latest analysis for thyssenkrupp nucera KGaA.
Despite the latest collaboration news, thyssenkrupp nucera KGaA’s share price return has been under pressure, with the stock down 10.84% over 90 days and the 1 year total shareholder return declining 27.59%. This points to fading momentum despite recent operational progress.
If this green hydrogen push has your attention, it could be worth widening your research to other companies shaping the energy transition through the 33 power grid technology and infrastructure stocks
The collaboration in India points to a company with meaningful technology and ambitions, yet thyssenkrupp nucera’s share price has fallen sharply over the past year. Is that disconnect offering value, or does it reflect what investors already see?
Most Popular Narrative: 29.1% Undervalued
Compared with thyssenkrupp nucera KGaA’s last close at €7.61, the most followed narrative estimates fair value at €10.74, implying a sizeable gap in expectations.
Recent project delays and smaller average project size have weighed on near-term revenues, but thyssenkrupp nucera sits at the center of a major long-term shift as global decarbonization policies and corporate net-zero mandates support the structural ramp-up in green hydrogen demand, likely driving a reacceleration in order intake and revenue growth as regulatory certainty and infrastructure buildout progresses.
Curious how that long dated order book, shifting revenue mix, margin rebuild and future earnings multiple all fit together into a single valuation story? The full narrative joins those moving parts into a detailed roadmap that explains why €10.74 emerges as the anchor figure.
Result: Fair Value of €10.74 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear risks to the thyssenkrupp nucera KGaA narrative, including project delays, softer green hydrogen order intake and reliance on a few large contracts.
Find out about the key risks to this thyssenkrupp nucera KGaA narrative.
Another View On thyssenkrupp nucera KGaA’s Valuation
While the narrative points to a fair value of €10.74, the current market pricing of thyssenkrupp nucera KGaA looks very different when using a simple sales based yardstick. The stock trades on a P/S of 1.7x, compared with 0.6x for both peers and the wider European Construction industry, and a fair ratio of 0.4x that our model suggests the market could move toward. That gap implies investors today are paying a clear premium for each euro of revenue, so a key question is whether the long term hydrogen story justifies that extra price tag.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed messages in the thyssenkrupp nucera KGaA story can make it hard to know what really matters, so take a moment to review the underlying data and pressure test the optimism around rewards for yourself with the 1 key reward
Looking for more investment ideas beyond thyssenkrupp nucera KGaA?
If you stop your research here, you might miss stocks that better match your goals, so take a few minutes to scan other opportunities and keep your watchlist sharp.
- Target income potential with companies screened for resilient payouts and stronger yields through the 467 dividend fortresses.
- Hunt for mispriced opportunities where quality and valuation intersect using the 232 high quality undervalued stocks.
- Zero in on companies with sturdier finances and cleaner balance sheets via the solid balance sheet and fundamentals stocks screener (421 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com